CONMED Corporation (CNMD)
NYSE: CNMD · IEX Real-Time Price · USD
75.09
+0.37 (0.50%)
May 20, 2024, 2:45 PM EDT - Market open

CONMED Revenue

CONMED had revenue of $1.26B in the twelve months ending March 31, 2024, with 14.83% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $312.27M with 5.69% year-over-year growth. In the year 2023, CONMED had annual revenue of $1.24B with 19.06% growth.

Revenue (ttm)
$1.26B
Revenue Growth
+14.83%
P/S Ratio
1.82
Revenue / Employee
$315,387
Employees
4,000
Market Cap
2.31B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.24B199.27M19.06%
Dec 31, 20221.05B34.84M3.45%
Dec 31, 20211.01B148.18M17.18%
Dec 31, 2020862.46M-92.64M-9.70%
Dec 31, 2019955.10M95.46M11.11%
Dec 31, 2018859.63M63.24M7.94%
Dec 31, 2017796.39M32.87M4.31%
Dec 31, 2016763.52M44.35M6.17%
Dec 31, 2015719.17M-20.89M-2.82%
Dec 31, 2014740.06M-22.65M-2.97%
Dec 31, 2013762.70M-4.44M-0.58%
Dec 31, 2012767.14M42.06M5.80%
Dec 31, 2011725.08M11.35M1.59%
Dec 31, 2010713.72M18.98M2.73%
Dec 31, 2009694.74M-47.44M-6.39%
Dec 31, 2008742.18M47.90M6.90%
Dec 31, 2007694.29M47.48M7.34%
Dec 31, 2006646.81M29.51M4.78%
Dec 31, 2005617.31M58.92M10.55%
Dec 31, 2004558.39M61.26M12.32%
Dec 31, 2003497.13M44.07M9.73%
Dec 31, 2002453.06M24.34M5.68%
Dec 31, 2001428.72M32.85M8.30%
Dec 31, 2000395.87M19.65M5.22%
Dec 31, 1999376.23M39.78M11.82%
Dec 31, 1998336.44M198.17M143.32%
Dec 31, 1997138.27M12.64M10.06%
Dec 31, 1996125.63M26.07M26.19%
Dec 31, 199599.56M28.49M40.10%
Dec 31, 199471.06M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Patterson Companies 6.57B
Indivior 1.12B
Myriad Genetics 774.20M
NovoCure 525.66M
Vericel 207.78M
RxSight 101.10M
Rhythm Pharmaceuticals 91.93M
Geron 520.00K
Revenue Rankings